# Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction

> **NCT00573144** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 59 (actual)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Nesiritide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00573144
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2012-11
- **Final completion:** 2013-04
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2014-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00573144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00573144, "Nesiritide Therapy to Preserve Function of the Left Ventricle After Myocardial Infarction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00573144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*